Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Double-Blind, Randomized, Three-Way Crossover, Placebo-Controlled, Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis on Standard Therapy

NCT01268280 is registered in ClinicalTrials.gov with Cytokinetics as lead sponsor.

NCT NCT01268280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01268280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Double-Blind, Randomized, Three-Way Crossover, Placebo-Controlled, Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis on Standard Therapy
Lead sponsor
Cytokinetics
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2010
Completion date
October 31, 2012
Enrollment
32 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis